The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Bayer; Novartis; Pfizer
Research Funding - Bayer; Novartis
A multinational phase II clinical trial of neoadjuvant imatinib for large gastrointestinal stromal tumor of the stomach.
 
Han-Kwang Yang
Research Funding - Novartis (Inst)
 
Yukinori Kurokawa
Honoraria - Novartis; Pfizer
 
Min-Hee Ryu
Honoraria - Novartis
Consulting or Advisory Role - Novartis
Research Funding - Novartis
 
Haruhiko Cho
Honoraria - Bayer; Novartis; Pfizer
 
Sook Ryun Park
No Relationships to Disclose
 
Toru Masuzawa
No Relationships to Disclose
 
Hyuk-Joon Lee
Research Funding - JW Pharmaceutical (Inst); Olympus (Inst)
 
Sohei Matsumoto
No Relationships to Disclose
 
Oh Kyoung Kwon
No Relationships to Disclose
 
Hiroshi Honda
No Relationships to Disclose
 
Kyung Hee Lee
No Relationships to Disclose
 
Kazuyoshi Yamamoto
No Relationships to Disclose
 
Seong-Ho Kong
No Relationships to Disclose
 
Takashi Ishikawa
No Relationships to Disclose
 
Jeong Hwan Yook
No Relationships to Disclose
 
Kazuhito Nabeshima
No Relationships to Disclose
 
Seokyung Hahn
Consulting or Advisory Role - Roche
Research Funding - Actelion; Novartis
 
Toshio Shimokawa
No Relationships to Disclose
 
Yoon-Koo Kang
Consulting or Advisory Role - Lilly/ImClone; Novartis; Ono Pharmaceutical; Roche/Genentech; Taiho Pharmaceutical
Research Funding - Bayer; Novartis; Roche/Genentech
 
Toshirou Nishida
No Relationships to Disclose